Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications
- PMID: 17650055
Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications
Abstract
One of the great challenges of long-term treatment of schizophrenia and related disorders is minimizing the medical or psychological burden from persistent side effects. Because of the differences in side effect profiles between the newer and older antipsychotic medications, and distinct differences among the newer agents themselves, the spectrum of side effects associated with antipsychotic therapy has changed tremendously. The authors review changing from one antipsychotic to another ("switching") as a potential treatment strategy for reducing the overall side effect burden of antipsychotic therapy. This review identifies 6 steps to the evaluation of switching antipsychotics because of side effects: (1) Establish a causal attribution that the clinical problem is an adverse effect of the antipsychotic medication; (2) Understand the course of the side effect, especially regarding present and future risks for the individual patient receiving the antipsychotic treatment; (3) Understand the potential risks and benefits of other side effect interventions that do not require switching the antipsychotic; (4) Be aware of the side effect profiles of other possible antipsychotics, with an understanding of the potential effectiveness of changing (switching) to another antipsychotic for this side effect; (5) Calculate the side effect risks of switching antipsychotics; (6) Calculate the efficacy risks of switching antipsychotics. The authors explain how to evaluate the specific side effect in the context of the current medication and the overall management of the patient.
Similar articles
-
Strategies for dosing and switching antipsychotics for optimal clinical management.J Clin Psychiatry. 2008;69 Suppl 1:4-17. J Clin Psychiatry. 2008. PMID: 18484804 Review.
-
[Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].Encephale. 2009 Apr;35(2):129-38. doi: 10.1016/j.encep.2008.03.007. Epub 2008 Jul 7. Encephale. 2009. PMID: 19393381 French.
-
Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia.J Clin Psychiatry. 2007;68 Suppl 4:34-9. J Clin Psychiatry. 2007. PMID: 17539698 Review.
-
Switching antipsychotics: an updated review with a focus on quetiapine.J Psychopharmacol. 2006 Jan;20(1):104-18. doi: 10.1177/0269881105056668. Epub 2005 Oct 4. J Psychopharmacol. 2006. PMID: 16204323 Review.
-
Abstinence, anticipation, reduction, and treatment (AART): a stepwise approach to the management of atypical antipsychotic side effects.Essent Psychopharmacol. 2006;7(1):1-14. Essent Psychopharmacol. 2006. PMID: 16989288 Review.
Cited by
-
[Adherence to psychopharmacological treatment: Psychotherapeutic strategies to enhance adherence].Nervenarzt. 2015 May;86(5):637-46; quiz 647-8. doi: 10.1007/s00115-015-4275-z. Nervenarzt. 2015. PMID: 25903501 German.
-
A roadmap to key pharmacologic principles in using antipsychotics.Prim Care Companion J Clin Psychiatry. 2007;9(6):444-54. Prim Care Companion J Clin Psychiatry. 2007. PMID: 18185824 Free PMC article. No abstract available.
-
SMARTS (Systematic Monitoring of Adverse events Related to TreatmentS): The development of a pragmatic patient-completed checklist to assess antipsychotic drug side effects.Ther Adv Psychopharmacol. 2014 Feb;4(1):15-21. doi: 10.1177/2045125313510195. Ther Adv Psychopharmacol. 2014. PMID: 24490026 Free PMC article.
-
Aripiprazole: from pharmacological profile to clinical use.Neuropsychiatr Dis Treat. 2015 Oct 13;11:2635-47. doi: 10.2147/NDT.S88117. eCollection 2015. Neuropsychiatr Dis Treat. 2015. PMID: 26508859 Free PMC article. Review.
-
Consumers' questions about antipsychotic medication: revealing safety concerns and the silent voices of young men.Soc Psychiatry Psychiatr Epidemiol. 2015 May;50(5):725-33. doi: 10.1007/s00127-014-1005-y. Epub 2014 Dec 30. Soc Psychiatry Psychiatr Epidemiol. 2015. PMID: 25547083
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources